Target intelligence / Profile preview

CACNB2 antisense RNA 2 (CACNB2-AS2)

Target
CACNB2-AS2
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

CACNB2 antisense RNA 2 (CACNB2-AS2) is a long non-coding RNA (lncRNA) transcribed from the strand opposite that of the CACNB2 gene[7]. Antisense RNAs such as CACNB2-AS2 often modulate the expression of their sense gene counterparts (here, CACNB2), potentially impacting RNA stability, translation, or splicing through cis or trans regulatory mechanisms[2][6]. However, there are currently no peer-reviewed studies specifically characterizing the function, regulatory role, or disease relevance of CACNB2-AS2. Most available information is based on automated gene annotation, and there is no evidence that this RNA is a direct therapeutic target, nor are there clinically relevant drugs, mechanisms of action, or biomarker uses attributed to it at this time[7].

02

Mechanism of action

Not applicable; no drugs or interventions directly linked

03

Biological functions

Potential gene regulation (generic for antisense RNA)No specific documented function for CACNB2-AS2
04

Disease associations

None specifically attributed to CACNB2-AS2; however, dysregulated antisense RNAs are broadly linked to diseases such as cardiovascular disease, cancer, and diabetes in general

Beyond the preview

Go deeper on CACNB2 antisense RNA 2 (CACNB2-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CACNB2 antisense RNA 2 (CACNB2-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call